Yao C et al. [80] found that the improvements of AD caused by Celastrol were reversed by means of treatment with MRGPRX2 overexpression, indicating that Celastrol might affect AD via MRGPRX2. This evidence concerns the gene MRGPRX2 and Alzheimer disease.